🔎 Trials Near Me

Utama › Leukemia Mielomonositik Kronik › Florida

Kajian klinikal Leukemia Mielomonositik Kronik di Florida

8 kajian untuk Leukemia Mielomonositik Kronik sedang mencari peserta di lokasi di Florida.

Bandar di Florida

Teks kajian rasmi (Bahasa Inggeris)

A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.

  • University of Miami, Miami
Mengambil pesertaFasa 2Sukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Sep 2026 · NCT06566742

Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia

  • Moffitt Cancer Center, Tampa
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT07033598

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

  • Allergy, Asthma, & Immunology Associates of Tampa Bay, Tampa
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 12 Ogo 2026 · NCT07143669

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

  • University of Miami - Sylvester Comprehensive Cancer Center, Miami
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Apr 2026 · NCT04256317

A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

  • Moffitt Cancer Center, Tampa
Mengambil pesertaFasa 1
Umur 12 ke atas · Semua jantina · Dikemas kini 16 Mac 2026 · NCT06994676

A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)

  • Moffitt, Tampa
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Feb 2026 · NCT06950034

Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia

  • University of Miami - Miller School of Medicine, Miami
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 26 Ogo 2025 · NCT03850574

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.